# Inhibrx (INBX) — Earnings

INBX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/inbx/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2025 |
| Period end | Jun 30, 2025 |
| EPS actual | −$1.85 |
| EPS estimate | −$2.76 |
| EPS surprise | +32.97% |
| Revenue surprise | +0.00% |
| Revenue | $1.3M |
| Revenue estimate | $0.00 |
| Reported | Aug 13, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/2007919/000200791925000081/inhibrx-20250630.htm) |

Inhibrx reported Q2 2025 results on August 13, 2025. The company lost $1.85 per share, a smaller loss than the $2.76 analysts expected, a beat of 32.97%. Revenue was $1.3 million. No revenue estimate was given, so there is no revenue surprise to measure. The table has no Q2 2024 row, so there is no same-quarter comparison from a year earlier.

The record here is very short: just two quarters. The other one is Q4 2024, reported on March 17, 2025, when Inhibrx lost $3.09 per share against an expected loss of $2.89, a miss of 7.11%. Revenue in that quarter was $100,000. Both quarters were losses. Between the two reports, the loss per share narrowed by $1.24 and revenue rose from $100,000 to $1.3 million. Q1 2025 does not appear in the table, so the two figures are not consecutive quarters. With only two data points, the table does not show an established trend.

The table shows no report after Q2 2025, and two report dates are not enough to set a reliable reporting rhythm. A longer run of quarters will be needed before the record says much about where results are heading.

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2025 | Aug 13, 2025 | −$2.76 | −$1.85 | 32.97% | — | $1.3M |
| Q4 2024 | Mar 17, 2025 | −$2.89 | −$3.09 | -7.11% | — | $100,000.00 |

## Frequently Asked Questions

### When did Inhibrx (INBX) last report earnings?

Inhibrx last reported on Aug 13, 2025, covering fiscal Q2 2025.

### Did INBX beat earnings estimates?

Yes. Inhibrx reported EPS of −$1.85 for Q2 2025 against a −$2.76 estimate — a 32.97% beat.

### How much revenue did INBX report last quarter?

Inhibrx reported $1.3M in revenue for Q2 2025.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).